Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 71205-144

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 71205-144). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Image 01)

A forest plot chart showing various studies on risk or odds ratios related to a health outcome. The chart includes prospective cohort studies, retrospective cohort studies, case-control studies, and non-fatal idiopathic cases, with data points represented as diamonds and confidence intervals as horizontal lines on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Fig 2 (Image 02)

A bar chart showing the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC users (ranges 1 to 5), COC users (ranges 3 to 9), Pregnancy (ranges 5 to 20), and Postpartum within 12 weeks (ranges 40 to 65). The chart includes a note that pregnancy data is based on actual pregnancy duration and model assumptions.*

FDA Label Image

Drospirenone Usp Structure (Image 03)

Chemical structure of the active ingredient drospirenone, as shown in the image associated with the drospirenone and ethinyl estradiol kit by Proficient Rx LP.*

FDA Label Image

Ethinyl Estradiol Usp Structure (Image 04)

Chemical structure of the active ingredient ethinyl estradiol, showing its molecular framework with hydroxyl groups and characteristic steroid rings.*

FDA Label Image

71205-144-28 (Image 05)

Label for drospirenone 3 mg and ethinyl estradiol 0.02 mg tablets, a 28-day kit containing 28 tablets. The label includes the NDC 71205-144-28 and indicates it is prescription only. The product is relabeled by Proficient Rx LP, Thousand Oaks, CA, with manufacturing credited to Glenmark Pharmaceuticals Ltd, India. It includes cautions to see the package insert and keep medication out of reach of children.*

FDA Label Image

Blister (Image 07)

An instructional diagram showing a hand peeling back a tablet from a blister pack of Drospirenone and Ethinyl Estradiol Tablets, USP 3 mg/0.02 mg. The blister pack is organized into weeks and days to guide daily medication use, with a note indicating the package is not child resistant.*

FDA Label Image

Likelihood Of Developing A Serious Blood Blot (Image 08)

A horizontal bar chart showing the number of women with a blood clot per 10,000 women years (WY) for four groups: Non-Pregnant Non-COC user, COC-User, Pregnancy, and Postpartum (12 weeks only). The chart indicates ranges from 1 to 5 for Non-Pregnant Non-COC users, 3 to 9 for COC-Users, 5 to 20 for Pregnancy, and 40 to 65 for Postpartum. The pregnancy data is noted to be based on actual pregnancy duration in reference studies with additional model assumptions on pregnancy duration.*

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.